| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.718 | 0.002 | 0.718 | Leukotriene D4 antagonist | 0.053 0.009 CID_154699754 | ||
| 0.598 | 0.011 | 0.598 | 5 Hydroxytryptamine release inhibitor | |||
| 0.542 | 0.002 | 0.542 | Leukotriene antagonist | 0.073 0.038 CID_154699754 | ||
| 0.5 | 0.003 | 0.5 | Phosphodiesterase 3A inhibitor | |||
| 0.505 | 0.027 | 0.505 | Histamine release inhibitor | 0.209 0.192 CID_154699754 | ||
| 0.444 | 0.002 | 0.444 | Phosphodiesterase 7B inhibitor | |||
| 0.408 | 0.002 | 0.408 | Glutamate (mGluR2) antagonist | |||
| 0.407 | 0.002 | 0.407 | Glutamate (mGluR group II) antagonist | |||
| 0.399 | 0.004 | 0.399 | Glutamate receptor agonist | |||
| 0.356 | 0.009 | 0.356 | Phosphodiesterase inhibitor | |||
| 0.332 | 0.005 | 0.332 | Catenin beta inhibitor | |||
| 0.306 | 0.002 | 0.306 | Angiotensin AT1A receptor antagonist | |||
| 0.307 | 0.005 | 0.307 | Glutamate (mGluR) agonist | |||
| 0.345 | 0.052 | 0.345 | Lipoxygenase inhibitor | |||
| 0.297 | 0.005 | 0.297 | Glutamate (mGluR) antagonist | 0.161 0.015 CID_154699754 | ||
| 0.289 | 0.005 | 0.289 | Alcohol dehydrogenase inhibitor | |||
| 0.287 | 0.004 | 0.287 | Phosphodiesterase III inhibitor | |||
| 0.276 | 0.004 | 0.276 | Glutamate (mGluR group II) agonist | |||
| 0.272 | 0.004 | 0.272 | Glutamate (mGluR2) agonist | |||
| 0.288 | 0.02 | 0.288 | I kappa B kinase epsilon inhibitor | |||
| 0.279 | 0.018 | 0.279 | Hemostatic | |||
| 0.266 | 0.013 | 0.266 | Glutamate receptor antagonist | 0.223 0.02 CID_154699754 | ||
| 0.225 | 0.004 | 0.225 | Phosphodiesterase 3B inhibitor | |||
| 0.225 | 0.004 | 0.225 | Myeloperoxidase inhibitor | |||
| 0.216 | 0.005 | 0.216 | Leukotriene synthesis inhibitor | |||
| 0.195 | 0.002 | 0.195 | Leukotriene C antagonist | |||
| 0.195 | 0.004 | 0.195 | Leukotriene B4 antagonist | |||
| 0.181 | 0.003 | 0.181 | Angiotensin AT2 receptor antagonist | |||
| 0.174 | 0.002 | 0.174 | Leukotriene C4 antagonist | |||
| 0.162 | 0.005 | 0.162 | Phosphodiesterase X inhibitor | |||
| 0.162 | 0.005 | 0.162 | Phosphodiesterase 10A inhibitor | |||
| 0.15 | 0.005 | 0.15 | Phosphodiesterase 1C inhibitor | |||
| 0.138 | 0.004 | 0.138 | Bombesin 3 receptor antagonist | |||
| 0.136 | 0.008 | 0.136 | Phosphodiesterase 1B inhibitor | |||
| 0.13 | 0.005 | 0.13 | Nicotinic acid receptor 2 agonist | |||
| 0.128 | 0.005 | 0.128 | AMPA 2 receptor antagonist | |||
| 0.131 | 0.01 | 0.131 | Prostaglandin E2 antagonist | |||
| 0.154 | 0.036 | 0.154 | 5-Lipoxygenase inhibitor | |||
| 0.116 | 0.003 | 0.116 | Angiotensin II receptor antagonist | |||
| 0.133 | 0.021 | 0.133 | Toll-Like receptor 3 antagonist | |||
| 0.141 | 0.033 | 0.141 | Mediator release inhibitor | |||
| 0.118 | 0.013 | 0.118 | Phosphodiesterase 4A inhibitor | |||
| 0.128 | 0.03 | 0.128 | Phosphodiesterase IV inhibitor | |||
| 0.107 | 0.01 | 0.107 | Phosphodiesterase VII inhibitor | |||
| 0.116 | 0.019 | 0.116 | Phosphodiesterase 4B inhibitor | |||
| 0.103 | 0.007 | 0.103 | Sphingosine kinase 2 inhibitor | |||
| 0.094 | 0.003 | 0.094 | Angiotensin AT1 receptor antagonist | |||
| 0.118 | 0.028 | 0.118 | Phosphodiesterase I inhibitor | |||
| 0.108 | 0.024 | 0.108 | Peroxisome proliferator-activated receptor gamma agonist | |||
| 0.087 | 0.004 | 0.087 | Leukotriene B4 receptor 1 antagonist | |||
| 0.093 | 0.011 | 0.093 | Phosphodiesterase 1A inhibitor | |||
| 0.213 | 0.137 | 0.213 | 12-Lipoxygenase inhibitor | |||
| 0.136 | 0.065 | 0.136 | NADPH oxidase inhibitor | |||
| 0.101 | 0.036 | 0.101 | Phosphodiesterase 4D inhibitor | |||
| 0.234 | 0.169 | 0.234 | GABA C receptor rho-3 antagonist | |||
| 0.079 | 0.016 | 0.079 | MAP kinase kinase 9 inhibitor | |||
| 0.071 | 0.01 | 0.071 | Immunoglobulin Fc receptor antagonist | |||
| 0.085 | 0.028 | 0.085 | Phosphodiesterase VIII inhibitor | |||
| 0.067 | 0.017 | 0.067 | Oleamide hydrolase inhibitor | |||
| 0.054 | 0.005 | 0.054 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.104 | 0.057 | 0.104 | Xanthine oxidase inhibitor | |||
| 0.05 | 0.004 | 0.05 | 5 Lipoxygenase activating protein inhibitor | |||
| 0.067 | 0.022 | 0.067 | AMPA receptor antagonist | |||
| 0.05 | 0.008 | 0.05 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | |||
| 0.058 | 0.016 | 0.058 | Benzodiazepine inverse agonist | |||
| 0.058 | 0.02 | 0.058 | NMDA receptor subunit 3B antagonist | |||
| 0.071 | 0.033 | 0.071 | Protease activated receptor antagonist | |||
| 0.064 | 0.028 | 0.064 | Phosphodiesterase II inhibitor | |||
| 0.065 | 0.029 | 0.065 | Prostaglandin antagonist | |||
| 0.059 | 0.025 | 0.059 | Carbonic anhydrase II stimulant | |||
| 0.044 | 0.011 | 0.044 | AMPA 3 receptor antagonist | |||
| 0.075 | 0.043 | 0.116 | Glutamate (mGluR group I) antagonist | 0.116 0.021 CID_154699754 | CID_154699754 | |
| 0.057 | 0.026 | 0.057 | Phosphodiesterase 2A inhibitor | |||
| 0.035 | 0.006 | 0.035 | Leukotriene B4 receptor 2 antagonist | |||
| 0.045 | 0.018 | 0.045 | Glucagon-like peptide 1 receptor antagonist | |||
| 0.061 | 0.033 | 0.061 | Phosphodiesterase 4C inhibitor | |||
| 0.044 | 0.016 | 0.044 | CF transmembrane conductance regulator antagonist | |||
| 0.057 | 0.03 | 0.057 | Sphingosine 1-phosphate receptor 5 agonist | |||
| 0.047 | 0.022 | 0.047 | Factor XIa inhibitor | |||
| 0.061 | 0.037 | 0.061 | Sphingosine kinase inhibitor | |||
| 0.189 | 0.166 | 0.189 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.028 | 0.007 | 0.028 | Free fatty acid receptor 1 agonist | |||
| 0.024 | 0.005 | 0.024 | Angiotensin AT1B receptor antagonist | |||
| 0.08 | 0.063 | 0.08 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | |||
| 0.04 | 0.024 | 0.04 | Carbonic anhydrase I stimulant | |||
| 0.034 | 0.018 | 0.034 | AMPA 1 receptor antagonist | |||
| 0.038 | 0.023 | 0.038 | Nicotinic acid receptor agonist | |||
| 0.021 | 0.008 | 0.021 | Complement factor D inhibitor | |||
| 0.057 | 0.045 | 0.057 | Collagenase 3 inhibitor | |||
| 0.026 | 0.016 | 0.026 | Kainate receptor 4 antagonist | |||
| 0.067 | 0.06 | 0.067 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.053 | 0.046 | 0.053 | Fatty acid synthase inhibitor | |||
| 0.087 | 0.081 | 0.087 | Bile acid receptor antagonist | |||
| 0.029 | 0.024 | 0.029 | CXC chemokine 3 receptor antagonist | |||
| 0.037 | 0.032 | 0.037 | AMPA 4 receptor antagonist | |||
| 0.024 | 0.02 | 0.024 | Prostaglandin EP4 antagonist | |||
| 0.059 | 0.056 | 0.059 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.081 | 0.079 | 0.238 | Breast cancer-resistant protein inhibitor | 0.238 0.01 CID_154699754 | CID_154699754 | |
| 0.096 | 0.095 | 0.096 | MAO inhibitor | |||
| 0.041 | 0.04 | 0.104 | Glutamate (mGluR5) antagonist | 0.104 0.009 CID_154699754 | CID_154699754 | |
| 0.08 | 0.235 | 0.122 | DNA repair enzyme inhibitor | 0.122 0.069 CID_154699754 | CID_154699754 | |
| 0.042 | 0.221 | 0.088 | Uric acid excretion stimulant | 0.088 0.068 CID_154699754 | CID_154699754 | |
| 0.004 | 0.2 | 0.017 | Adenosine A2 receptor agonist | 0.017 0.01 CID_154699754 | CID_154699754 | |
| 0.033 | 0.232 | 0.078 | Adenosine A3 receptor antagonist | 0.078 0.046 CID_154699754 | CID_154699754 | |
| 0.095 | 0.295 | 0.267 | Hypoglycemic | 0.267 0.067 CID_154699754 | CID_154699754 | |
| 0.032 | 0.238 | 0.066 | Adenine nucleotide translocase inhibitor | 0.066 0.019 CID_154699754 | CID_154699754 | |
| 0.038 | 0.251 | 0.116 | Aminoacyl-tRNA synthetase inhibitor | 0.116 0.032 CID_154699754 | CID_154699754 | |
| 0.043 | 0.26 | 0.092 | NADH dehydrogenase inhibitor | 0.092 0.054 CID_154699754 | CID_154699754 | |
| 0.008 | 0.226 | 0.047 | Sodium/glucose cotransporter inhibitor | 0.047 0.005 CID_154699754 | CID_154699754 | |
| 0.006 | 0.229 | 0.016 | Adenosine A2b receptor agonist | 0.016 0.009 CID_154699754 | CID_154699754 | |
| 0.005 | 0.239 | 0.038 | Sodium/glucose cotransporter 2 inhibitor | 0.038 0.009 CID_154699754 | CID_154699754 | |
| 0.127 | 0.409 | 0.769 | Cyclophilin D inhibitor | 0.769 0.008 CID_154699754 | CID_154699754 | |
| 0.047 | 0.362 | 0.203 | Hypolipemic | 0.203 0.092 CID_154699754 | CID_154699754 | |
| 0.027 | 0.357 | 0.103 | UDP-glucose 4-epimerase inhibitor | 0.103 0.057 CID_154699754 | CID_154699754 | |
| 0.045 | 0.375 | 0.101 | Adenylate kinase inhibitor | 0.101 0.066 CID_154699754 | CID_154699754 | |
| 0.026 | 0.385 | 0.101 | AMP-activated protein kinase stimulant | 0.101 0.069 CID_154699754 | CID_154699754 | |
| 0.005 | 0.366 | 0.016 | Adenosine A3 receptor agonist | 0.016 0.013 CID_154699754 | CID_154699754 | |
| 0.071 | 0.454 | 0.169 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.169 0.11 CID_154699754 | CID_154699754 | |
| 0.039 | 0.468 | 0.346 | DNA methylase inhibitor | 0.346 0.017 CID_154699754 | CID_154699754 | |
| 0.005 | 0.466 | 0.054 | Adenosine A1 receptor antagonist | 0.054 0.045 CID_154699754 | CID_154699754 | |
| 0.043 | 0.509 | 0.189 | Hepatoprotectant | 0.189 0.073 CID_154699754 | CID_154699754 | |
| 0.004 | 0.49 | 0.032 | Adenosine A1 receptor agonist | 0.032 0.01 CID_154699754 | CID_154699754 | |
| 0.032 | 0.533 | 0.233 | Platelet adhesion inhibitor | 0.233 0.055 CID_154699754 | CID_154699754 | |
| 0.026 | 0.536 | 0.282 | DNA methyltransferase I inhibitor | 0.282 0.033 CID_154699754 | CID_154699754 | |
| 0.01 | 0.586 | 0.111 | Topoisomerase I inhibitor | 0.111 0.061 CID_154699754 | CID_154699754 | |
| 0.004 | 0.687 | 0.014 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.014 0.012 CID_154699754 | CID_154699754 | |
| 0.008 | 0.762 | 0.17 | Platelet antagonist | 0.17 0.126 CID_154699754 | CID_154699754 | |
| 0.009 | 0.818 | 0.459 | Antibacterial | 0.459 0.054 CID_154699754 | CID_154699754 | |
| 0.019 | 0.832 | 0.292 | Antiinflammatory | 0.292 0.223 CID_154699754 | CID_154699754 | |
| 0.013 | 0.889 | 0.122 | DNA polymerase I inhibitor | 0.122 0.067 CID_154699754 | CID_154699754 | |
| 0.038 | 0.915 | 0.202 | Interleukin 2 agonist | 0.202 0.186 CID_154699754 | CID_154699754 | |
| 0.007 | 0.91 | 0.238 | Angiogenesis stimulant | 0.238 0.076 CID_154699754 | CID_154699754 | |
| 0.006 | 0.936 | 0.268 | Apoptosis agonist | 0.268 0.197 CID_154699754 | CID_154699754 | |
| 0.031 | 0.992 | 0.278 | Peptidyltransferase inhibitor | 0.278 0.034 CID_154699754 | CID_154699754 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |